Opinion · 29 Nov 2025
Conference abstractPublished 4 Jul 2019
Experimentally designed tizanidine hydrochloride aspasomes as nanocarriers for transdermal drug delivery: In-Vitro evaluation and In-Vivo assessment
National Research Centre, Egypt Cairo University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the present study, aspasomes were developed to enhance the in-vitro dissolution and the in-vivo performance for tizanidine hydrochloride (TZN), a skeletal muscle relaxant with low oral bioavailability. A Full factorial experimental design was applied to statistically optimize the formulation variables: the amount of drug, amount of ascorbyl palmitate (AP) and the amount of span 60 on the entrapment efficiency, the vesicle size and the invitro release. Aspasomal formulation (TZN-AS 6) composed of 20 mg TZN, 50 mg AP and 50 mg span60 was obtained by employing the desirability function of Design-Expert® software. It exhibited encapsulation efficiency of 95.0 % and smooth surface with particle size 191.8 nm. In addition, skin permeation profile was obtained using static vertical diffusion Franz cells and hairless mouse skin treated with TZN-AS 6 aspasomes 0.2% (w/w) TZN, and compared with unformulated drug. Ex-vivo drug permeation across rat skin for TZN-AS 6 showed a superior skin permeation potential with the highest enhancement ratio value compared to the unformulated drug (ER=4.4). The pharmacokinetic study revealed that aspasomes formulation successively enhanced the bioavailability of TZN compared to oral drug. In conclusion, aspasomes could serve as an effective transdermal delivery of tizanidine hydrochloride.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Formulation Science & Bioavailability.
Opinion · 29 Nov 2025
Advanced Nanodrug Delivery for Poorly Soluble Drugs
Commentary · 29 Nov 2025
Oral Biopharmaceutical Delivery: Advanced Formulation Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Formulation Science & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hadeer A. El-Hashemy”
- BylineArticles whose byline prints “Rawia M. Khalil”
- BylineArticles whose byline prints “Silvia Kocova El Arini”
- BylineArticles whose byline prints “Mona Basha”
- BylineArticles whose byline prints “Ahmed Abdelbary”
